Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 3 (4), 261-267
- https://doi.org/10.1016/0882-4010(87)90059-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- MENINGOCOCCAL SEROTYPES AND SEROGROUP B DISEASE IN NORTH-WEST EUROPEThe Lancet, 1986
- Neisseria meningitidis type 15/subtype Pl. 16 in the NetherlandsAntonie van Leeuwenhoek, 1986
- Meningococcal disease in NorwayAntonie van Leeuwenhoek, 1986
- Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of SerotypesClinical Infectious Diseases, 1985
- ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITISThe Lancet, 1983
- Meningococcal Disease: Still with UsClinical Infectious Diseases, 1983
- Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.The Journal of Experimental Medicine, 1978
- Neisseria meningitidis Infections in Northern Norway: An Epidemic in 1974-1975 Due Mainly to Group B OrganismsThe Journal of Infectious Diseases, 1977
- Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model.The Journal of Experimental Medicine, 1976
- Immunologic Response of Man to Group B Meningococcal Polysaccharide VaccinesThe Journal of Infectious Diseases, 1972